Table 1 Clinical characteristics of the patients included in the study
Characteristics | Patients |
|---|---|
Gender (M/F) | 15/9 |
Age (years): median ± standard deviation | 25.50 ± 17.24 |
Mean duration of symptoms before presentation (wks) | 6.54 ± 3.95 |
Antibody titer (CSF) | Â |
 Weakly positive | 4 |
 Positive | 10 |
 Strongly positive | 10 |
Primary neuropsychiatric symptoms | Â |
 Epileptic seizures | 18 |
 Memory impairment | 13 |
 Psychiatric symptom | 12 |
 Movement disorders | 9 |
Treated with drugs within 24Â h before PET/CT | Â |
 Steroids and gamma globulin | 3 |
 Steroids | 3 |
 Gamma globulin | 2 |
 Sedative and steroids | 1 |
 Sedative | 1 |
Whole-body scanning or brain scanning | Â |
 Whole-body scanning | 12 |
 Brain scanning | 12 |